Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 11 of 104 for:    Recruiting, Not yet recruiting, Available Studies | (idiopathic pulmonary fibrosis)

Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis (STRIVE-IPF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03286556
Recruitment Status : Recruiting
First Posted : September 18, 2017
Last Update Posted : September 13, 2019
Sponsor:
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI)
Brigham and Women's Hospital
Temple University
University of Pittsburgh
Information provided by (Responsible Party):
Steven R. Duncan, MD, University of Alabama at Birmingham

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 1, 2021
Estimated Study Completion Date : September 30, 2022
Publications of Results: